A complex genomic locus drives mtDNA replicase POLG expression to its disease-related nervous system regions

EMBO Mol Med. 2018 Jan;10(1):13-21. doi: 10.15252/emmm.201707993.

Abstract

DNA polymerase gamma (POLG), the mtDNA replicase, is a common cause of mitochondrial neurodegeneration. Why POLG defects especially cause central nervous system (CNS) diseases is unknown. We discovered a complex genomic regulatory locus for POLG, containing three functional CNS-specific enhancers that drive expression specifically in oculomotor complex and sensory interneurons of the spinal cord, completely overlapping with the regions showing neuronal death in POLG patients. The regulatory locus also expresses two functional RNAs, LINC00925-RNA and MIR9-3, which are coexpressed with POLG The MIR9-3 targets include NR2E1, a transcription factor maintaining neural stem cells in undifferentiated state, and MTHFD2, the regulatory enzyme of mitochondrial folate cycle, linking POLG expression to stem cell differentiation and folate metabolism. Our evidence suggests that distant genomic non-coding regions contribute to regulation of genes encoding mitochondrial proteins. Such genomic arrangement of POLG locus, driving expression to CNS regions affected in POLG patients, presents a potential mechanism for CNS-specific manifestations in POLG disease.

Keywords: POLG; enhancer; gene regulation; mtDNA maintenance; tissue specificity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Brain / metabolism
  • Cell Death
  • Central Nervous System Diseases / genetics*
  • DNA Polymerase gamma / genetics*
  • DNA, Mitochondrial / genetics*
  • Gene Expression Regulation*
  • Genetic Loci*
  • Humans
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Mitochondrial Proteins / genetics
  • Rats
  • Spinal Cord / metabolism

Substances

  • DNA, Mitochondrial
  • Mitochondrial Proteins
  • DNA Polymerase gamma
  • POLG protein, human
  • Polg protein, mouse